Position in NTLA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$220,450
+$53,419 QoQ
Shares Held
13,029
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#208
of 327 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $93,187,790 across 6 Biotechnology names. NTLA ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,075 | $53,684,094 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,479 | $32,099,214 | |
| 3 | MRNA |
Moderna, Inc.
|
86,677 | $6,069,989 | |
| 4 | INCY |
Incyte Corp
|
7,250 | $821,860 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
3,582 | $292,183 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
This page
|
13,029 | $220,450 |
All Filings in NTLA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,450 | 13,029 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $167,031 | 13,029 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $117,130 | 13,029 | Shares | Sole | 2026-02-13 | |
| 2022-03-31 | $13,080,600 | 180,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $21,283,200 | 180,000 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $24,147,000 | 180,000 | Shares | Sole | 2021-11-08 | |
| No filing history on record for this holder in this stock. | ||||||